Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Wright Medical Group Inc raises low end of FY 2014 revenue outlook to a range in line with analysts' estimates, reiterates EBITDA outlook, gives EPS outlook below analysts' estimates


Wednesday, 30 Apr 2014 04:03pm EDT 

Wright Medical Group Inc:Now expects FY 2014 net sales from continuing operations, or Extremity and Biologics revenue, of about $308 to $312 million (previous $305 to $312 million).Reiterates previously issued adjusted EBITDA from continuing operations of $(20.0) million to $(15.0) million.Adjusted earnings per share from continuing operations, including stock-based compensation, to be in the range of $(1.28) to $(1.38) per diluted share.FY 2014 revenue of $309 mln, EBITDA of $(16.31) mln and EPS of $(1.43) - Thomson Reuters I/B/E/S. 

Company Quote

31.3
-0.42 -1.32%
4:00pm EDT